Related Experiment Video
Updated: Jun 20, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Inhibition of TGF-beta1 promotes functional recovery after spinal cord injury
Masaaki Kohta1, Eiji Kohmura, Toshihide Yamashita
1Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Abstract:
Trauma to the spinal cord initiates a series of cellular and biochemical processes that damage both neurons and glia. TGF-beta and its receptors are expressed around the injury site following a spinal cord injury. Here, we report that the intrathecal administration of a neutralizing antibody to TGF-beta1 in rats with thoracic spinal cord contusion results in a significant enhancement of the locomotor recovery. The inhibition of TGF-beta1 suppresses glial scar formation and upregulates microglia/macrophage activation after the injury, presumably providing a favorable environment for restoration of the neural network. Rats treated with the anti-TGF-beta1 antibody exhibited a mild enhancement of growth and/or preservation of axons in the injured spinal cord caudal to the site of contusion. These results support the possibility of using TGF-beta1 inhibitors in the treatment of human spinal cord injuries.
Insights
Inhibiting TGF-beta1 after spinal cord injury in rats improved locomotor recovery. This treatment reduced glial scarring and promoted axon growth, suggesting potential for human spinal cord injury treatment.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Immunology
Background:
- Spinal cord injury (SCI) triggers damaging cellular and biochemical responses.
- Transforming growth factor-beta (TGF-beta) and its receptors are present at SCI sites.
- Current treatments for SCI have limited efficacy in restoring function.
Purpose of the Study:
- To investigate the therapeutic potential of neutralizing TGF-beta1 in a rat SCI model.
- To determine the effects of TGF-beta1 inhibition on locomotor recovery and neural tissue repair.
- To explore the impact of TGF-beta1 suppression on glial scar formation and immune cell activity.
Main Methods:
- Intrathecal administration of a neutralizing antibody against TGF-beta1 in rats with thoracic spinal cord contusion.
- Assessment of locomotor recovery using standardized behavioral scales.
- Histological analysis to evaluate glial scar formation, axon growth, and preservation caudal to the injury site.
- Monitoring of microglia/macrophage activation.
Main Results:
- Intrathecal anti-TGF-beta1 antibody treatment significantly enhanced locomotor recovery.
- Inhibition of TGF-beta1 suppressed glial scar formation around the injury site.
- TGF-beta1 blockade upregulated microglia/macrophage activation.
- A mild enhancement in axon growth and/or preservation was observed caudal to the contusion site.
Conclusions:
- Neutralizing TGF-beta1 is a promising therapeutic strategy for improving functional recovery after spinal cord injury.
- Inhibiting TGF-beta1 may create a more permissive environment for neural network restoration by modulating glial and immune responses.
- These findings support the development of TGF-beta1 inhibitors for clinical application in human SCI patients.
Related Concept Videos
TGF - β Signaling Pathway
Spinal Cord Injury ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
